Advertisement

Opioids pp 347-377 | Cite as

Regulation of Pituitary Proopiomelanocortin Gene Expression

  • J. L. Roberts
  • N. Levin
  • D. Lorang
  • J. R. Lundblad
  • S. Dermer
  • M. Blum
Chapter
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 104 / 1)

Abstract

The proopiomelanocortin (POMC) gene encodes the complex precursor to a variety of biologically active, important neuroendocrine peptides. It is expressed in a variety of tissues in the mammal, but its main site of expression is the pituitary anterior lobe corticotroph and, in some species, the intermediate lobe melanotroph. The POMC molecule is posttranslationally processed to different biologically active peptides in these two cell types, with adrenocorticotropic hormone (ACTH), β-lipotrophic hormone (β-LPH), and β-endorphin being major products in the corticotroph and a-melanocyte-stimulating hormone (α-MSH), corticotropin-like intermediate lobe peptide (CLIP), and acetyl-β-endorphin in the melanotroph (Eipper and Mains 1980). This array of different biological activities derived from the POMC molecule possibly necessitates the complex regulation of POMC peptide secretion and POMC gene expression observed in the pituitary. Regulation of POMC peptide secretion has recently been reviewed in several places (Antoni 1986; Jones and Gillham 1988). This review will deal primarily with the regulation of POMC gene expression in rat and mouse pituitary tissues, the species in which the majority of the work has been done although examples of other mammalian systems will be used where appropriate (see also Chaps. 14 and 26).

Keywords

Anterior Lobe Intermediate Lobe AtT20 Cell POMC mRNA POMC Gene 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abou-Samra AB, Catt KJ, Aguilera G (1986a) Involvement of protein kinase C in the regulation of adrenocorticotropin release from rat anterior pituitary cells. Endocrinology 118: 212–217PubMedGoogle Scholar
  2. Abou-Samra A-B, Catt KJ, Aguilera G (1987) Calcium-dependent control of corticotropin release in rat anterior pituitary cell cultures. Endocrinology 121: 965–974PubMedGoogle Scholar
  3. Affolter HU, Reisine T (1985) Corticotropin releasing factor increases proopiomelanocortin messenger RNA in mouse anterior pituitary tumor cells. J Biol Chem 260: 15477–15481PubMedGoogle Scholar
  4. Aguilera G, Harwood JP, Wilson JX, Morell J, Brown JH, Catt KJ (1983) Mechanisms of action of corticotropin releasing factor and other regulators of corticotropin release in rat pituitary cells. J Biol Chem 258: 8039–8045PubMedGoogle Scholar
  5. Akerblom IE, Slater EP, Beato M, Baxter JD, Mellon PL (1988) Negative regulation by glucocorticoids through intereference with a cAMP responsive enhancer. Science 241: 992–994Google Scholar
  6. Antakly T, Eisen HJ (1984) Immunocytochemical localization of glucocorticoid receptor in target cells. Endocrinology 115: 1984–1989PubMedGoogle Scholar
  7. Antakly T, Sasaki A, Liotta AS, Palkovits M, Krieger DT (1985) Induced expression of the glucocorticoid receptor in the rat intermediate pituitary lobe. Science 229: 277–279PubMedGoogle Scholar
  8. Antakly T, Mercille S, Cote JP (1987) Tissue-specific dopaminergic regulation of the glucocorticoid receptor in the rat pituitary. Endocrinology 120: 1558–1562PubMedGoogle Scholar
  9. Antoni FA (1986) Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor. Endo Rev 7: 351–378Google Scholar
  10. Autelitano DJ, Clements JA, Nikolaidis I, Canny BJ, Funder JW (1987) Concomitant dopaminergic and glucocorticoid control of pituitary proopiomelanocortin messenger ribonucleic acid and β-endorphin levels. Endocrinology 121: 1689–1696PubMedGoogle Scholar
  11. Autelitano DJ, Blum M, Roberts (1989) Changes in rat pituitary nuclear and cytoplasmic proopiomelanocortin RNAs associated with adrenalectomy and glucocorticoid replacement. Mol Cell Endocrinol 66: 171–80PubMedGoogle Scholar
  12. Autelitano DJ, Blum M, Lopingco M, Allen RG, Roberts JL (1990) Corticotropin-releasing factor differentially regulates anterior and intermediate pituitary lobe proopiomelanocortin gene transcription, nuclear precursor RNA and mature mRNA in vivo. Neuroendocrinology 51: 123–130PubMedGoogle Scholar
  13. Axelrod J, Reisine TD (1984) Stress hormones: their interaction and regulation. Science 224: 452PubMedGoogle Scholar
  14. Bilezikjian LM, Vale W (1983) Glucocorticoids inhibit CRF induced production of cAMP in cultured anterior pituitary cells. Endocrinology 113: 657–669PubMedGoogle Scholar
  15. Birnberg NC, Lissitzky JC, Hinman M, Herbert E (1983) Glucocorticoids regulate proopiomelanocortin gene expression in vivo at the levels of transcription and secretion. Proc Natl Acad Sci USA 80: 6982–6986PubMedGoogle Scholar
  16. Boutillier AL, Sassone-Corsi P, Loeffler JP (1991) The protooncogene c-fos is induced by corticotropin-releasing factor and stimulates proopiomelanocortin gene transcription in pituitary cells. Molec Endocrinol 5: 1301–1310Google Scholar
  17. Bruhn TA, Sutton RE, Rivier CL, Vale WW (1984) Corticotropin-releasing factor regulated proopiomelanocortin messenger ribonucleic acid levels in vivo. Neuroendocrinology 39: 170–175PubMedGoogle Scholar
  18. Buckingham JC (1979) The influence of corticosteroids on the secretion of corticotropin and its hypothalamic releasing hormone. J Physiol 286: 331PubMedGoogle Scholar
  19. Charron J, Drouin J (1986) Glucocorticoid inhibition of transcription from episomal proopiomelanocortin gene promoter. Proc Natl Acad Sci USA 83: 8903PubMedGoogle Scholar
  20. Chen CL, Dionne FT, Roberts JL (1984) Regulation of the pro-opiomelanocortin mRNA levels in rat pituitary by dopaminergic compounds. Proc Natl Sci USA 80: 2211Google Scholar
  21. Chronwall BM, Millington WR, Griffin WST, Unnerstall JR, O’Donohue TL (1987) Histological evaluation of the dopaminergic regulation of proopiomelanocortin gene expression in the intermediate lobe of the rat pituitary, involving in situ hybridization and [3H] thymidine uptake measurement. Endocrinology 120: 1201–1208PubMedGoogle Scholar
  22. Civelli O, Birnberg N, Herbert H (1982) Detection and quantitation of proopiomelanocortin mRNA in pituitary and brain tissues from different species. J Biol Chem 257: 6783–6790PubMedGoogle Scholar
  23. Cote TE, Frey EA, Sekura RD, Kebabian JW (1985) Dual regulation of adenylate cyclase activity and hormone release in the intermediate lobe of the rat pituitary gland: evidence for the involvement of membrane components of the stimulatory β-2-adrenergic system and of the inhibitory D-2 dopaminergic system. Adv Cyclic Nucleotide Res 19: 151–168Google Scholar
  24. Cote TE, Felder R, Kebabian JW, Sekura RD, Reisine T, Affolter HU (1986) D-2 dopamine receptor-mediated inhibition of pro-opiomelanocortin synthesis in rat intermediate lobe. J Biol Chem 261: 4555–4561PubMedGoogle Scholar
  25. Dallman MF, Makara GB, Roberts JL, Levin N, Blum M (1985) Corticotrope response to removal of releasing factors and corticosteroids in vivo. Endocrinology 117: 2190–2197PubMedGoogle Scholar
  26. Dave JR, Eiden LE, Lozovsky D, Waschek JA, Eskay RL (1987) Calcium-independent and calcium-dependent mechanisms regulate corticotropin-releasing factor-stimulated proopiomelanocortin peptide secretion and messenger ribonucleic acid production. Endocrinology 120: 305–310PubMedGoogle Scholar
  27. Diamond MI, Miner JN, Yoshinaga SK, Yamamoto KR (1990) Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science 249: 1266–1272PubMedGoogle Scholar
  28. Drouin J, Goodman HM (1980) Most of the coding region of rat ACTH beta-LPH precursor gene lacks intervening sequences. Nature 288: 610–614PubMedGoogle Scholar
  29. Drouin J, Chamberland M, Charron J, Jeannotte L, Nemer M (1985) Structure of the rat pro-opiomelanocortin ( POMC) gene. FEBS Lett 193: 54–58Google Scholar
  30. Drouin J, Nemer M, Charron J, Gagner JP, Jeannotte L, Sun YL, Therrein M, Tremblay Y (1989a) Tissue-specific activity of the pro-opiomelanocortin ( POMC) gene and repression by glucocorticoids. Genome 31: 510–519Google Scholar
  31. Drouin J, Trifiro MA, Plante RK, Nemer M, Eriksson, Wrange O (1989b) Glucocorticoid receptor binding to a specific DNA sequence is required for hormone-dependent repression of pro-opiomelanocortin gene transcription. Mol Cell Biol 9: 5302–5314Google Scholar
  32. Drouin J, Sun YL, Nemer M (1990) Regulatory elements of the pro-opiomelanocortin gene: pituitary specificity and glucocorticoid repression. Trends Endocrinol Metab 2: 219–225Google Scholar
  33. Eberwine JH, Roberts JL (1984) Glucocorticoid regulation of pro-opiomelanocortin gene transcription in the rat pituitary. J Biol Chem 259: 2166–2170PubMedGoogle Scholar
  34. Eberwine JH, Jonassen J, Dionne FT, Blum M, Roberts JL (1984) Catecholamine regulation of POMC gene expression in primary cultures and intact rat anterior and intermediate pituitary lobes. Abstracts of the 7th International Congress of Endocrinology, Quebec City (abstract 1003)Google Scholar
  35. Eberwine JH, Jonassen JA, Evinger MJQ, Roberts, JL (1987) Complex transcriptional regulation by glucocorticoids and corticotropin releasing hormone of proopiomelanocortin gene expression in rat pituitary cultures. DNA 6: 483–492PubMedGoogle Scholar
  36. Eipper BA, Mains RE (1980) Structure and biosynthesis of proadrenocorticotropin/endorphin and related peptides. Endo Rev 1: 1–27Google Scholar
  37. Fremeau RT, Lundblad JR, Pritchett DP, Wilcox JN, Roberts JL (1986) Regulation of POMC gene transcription in individual cell nuclei. Science 234: 1265–1269PubMedGoogle Scholar
  38. Gagner JP, Drouin J (1985) Opposite regulation of pro-opiomelanocortin gene transcription by glucocorticoids and CRH. Mol Cell Endocrinol 40: 25–32PubMedGoogle Scholar
  39. Gagner JP, Drouin J (1987) Tissue-specific regulation of pituitary proopiomelanocortin gene transcription by corticotropin-releasing hormone, 3’ 5’-cyclic adenosine monophosphate, and glucocorticoids. Mol Endocrinol 1: 677–682PubMedGoogle Scholar
  40. Gannon MN, Spencer R, Lundblad JR, McEwen BS, Roberts JL (1990) Pharmacological characterization of type II glucocorticoid binding sites in AtT20 pituitary cell culture. J Steroid Biochemistry 36: 83–88Google Scholar
  41. Gee CE, Roberts JL (1983) In situ hybridization histochemistry: a technique for study of gene expression in single cells. DNA 2: 157–168PubMedGoogle Scholar
  42. Giguere V, Labrie F, Cote J, Coy DH, Sueiras-Diaz J, Schally AV (1982) Stimulation of cyclic AMP accumulation and corticotropin release by synthetic ovine corticotropin-releasing factor in rat anterior pituitary cells; site of glucocorticoid action. Proc Natl Acad Sci USA 79: 3466–3459PubMedGoogle Scholar
  43. Gilles G, Lowry PJ (1978) Perfused rat isolated anterior pituitary cell column as bioassay for factor(s) controlling release of adrenocorticotropin: validation of a technique. Endocrinology 103: 521–529Google Scholar
  44. Guild S, Itoh Y, Kebabian JW, Luini A, Reisine T (1986) Forskolin enhances basal and potassium-evoked hormone release from normal and malignant pituitary tissue: the role of calcium. Endocrinology 118: 268–277PubMedGoogle Scholar
  45. Guild S, Reisine T (1987) Molecular mechanisms of corticotropin-releasing factor stimulation of calcium mobilization and adrenocorticotropin release from anterior pituitary tumor cells. J Pharm Exp Ther 241: 12551–12558Google Scholar
  46. Heisler S, Reisine TD, Hook VY, Axelrod J (1982) Somatostatin inhibits multireceptor stimulation of cyclic AMP formation and corticotropin secretion in mouse pituitary tumor cells. Proc Natl Acad Sci USA 79: 6502–6506PubMedGoogle Scholar
  47. Höllt V, Haarmann I, Seizinger BR, Herz A (1982) Chronic haloperidol treatment increases the level of in vitro translatable messenger ribonucleic acid coding for the β-endorphin/adrenocorticotropin precursor proopiomelanocortin in the pars intermedia of the rat pituitary. Endocrinology 110: 1885–1891PubMedGoogle Scholar
  48. Höllt V, Haarmann I (1984) Corticotropin-releasing factor differentially regulates proopiomelanocortin messenger ribonucleic acid levels in anterior as compared to intermediate pituitary lobes of rats. Biochem Biophys Res Commun 124: 407–415PubMedGoogle Scholar
  49. Israel A, Cohen SN (1985) Hormonally mediated negative regulation of human proopiomelanocortin gene expression after transfection into mouse L cells. Mol Cell Biol 5: 2443–2454PubMedGoogle Scholar
  50. Jeannotte L, Trifiro MA, Plante RK, Chamberland M, Drouin J (1987) Tissue- specific activity of the pro-opiomelanocortin gene promoter. Mol Cell Biol 7: 4058–4069PubMedGoogle Scholar
  51. Jingami H, Matsukura S, Numa S, Imura H (1985) Effects of adrenalectomy and dexamethasone administration on the level of preprocorticotropin-releasing factor messenger ribonucleic acid (mRNA) in the hypothalamus and adrenocorticotropin/beta-lipotropin precursor mRNA in the pituitary in rats. Endocrinology 117: 1314–1320PubMedGoogle Scholar
  52. Jones MT, Gillham B (1988) Factors involved in the regulation of adrenocorticotropic hormone/β-lipotropic hormone. Physiol Rev 68: 743–818PubMedGoogle Scholar
  53. Keller-Wood ME, Dallman MF (1984) Corticosteroid inhibition of ACTH secretion. Endo Rev 5: 1–36Google Scholar
  54. Kelsey JE, Watson SJ, Burke S, Akil H, Roberts JL (1986) Characterization of POMC mRNA detected by in situ hybridization. J Neuroscience 6: 38–49Google Scholar
  55. Lacaze-Masmonteil T, de Ketzer Y, Luton J-P, Kahn A, Bertagna X (1987) Characterization of proopiomelanocortin transcripts in human nonpituitary tissues. Proc Natl Acad Sci USA 84: 7261–7265PubMedGoogle Scholar
  56. Levin N, Blum M, Roberts JL (1989) Modulation of basal and corticotropin- releasing factor-stimulated proopiomelanocortin gene expression by vasopressin in rat anterior pituitary. Endocrinology 125: 2957–66PubMedGoogle Scholar
  57. Levin N, Roberts JL (1991) Positive regulation of proopiomelanocortin gene expression in corticotropes and melanotropes. 12: 1–22Google Scholar
  58. Litvin Y, Pasmantier R, Fleischer N, Erlichman J (1984) Hormonal activation of the cAMP dependent protein kinases in AtT20 cells. J Biol Chem 259: 10296–10304PubMedGoogle Scholar
  59. Liu B, Hammer G, Low MJ (1991) Characterization of the rat POMC gene sequences responsible for pituitary specific expression. Proceedings of the 21st Annual Meeting of the Society for Neuroscience, New Orleans. LA (abstract 211. 6 )Google Scholar
  60. Loeffler JP, Kley N, Pittius CW, Höllt V (1985) Corticotropin-releasing factor and forskolin increase proopiomelanocortin messenger RNA levels in rat anterior and intermediate cells in vitro. Neurosci Lett 62: 383–387PubMedGoogle Scholar
  61. Loeffler JP, Kley N, Pittius CW, Höllt V (1986) Calcium ion and cyclic adenosine 3’, 5’-monophosphate regulate proopiomelanocortin messenger ribonucleic acid levels in rat intermediate and anterior pituitary lobes. Endocrinology 119: 2840–2847PubMedGoogle Scholar
  62. Loeffler JP, Demeneix BA, Pittius CW, Kley N, Haegele KD, Höllt V (1987) GABA differentially regulates the gene expression of proopiomelanocortin in rat intermediate and anterior pituitary. Peptides 7: 253–259Google Scholar
  63. Lolait SJ, Clements JA, Markwick AJ, Cheng C, McNally M, Smith Al, Funder JW (1986) Proopiomelanocortin messenger ribonucleic acid and posttranslational processing of beta endorphin in spleen macrophages. J Clin Invest 77: 1776–1787PubMedGoogle Scholar
  64. Lorang D, Gillo B, Lundblad JR, Blum M, Roberts JL (1992) Calcium involvement in basal and CRH-stimulated POMC gene transcription. Mol Cell Biol (in press)Google Scholar
  65. Luini A, Lewis D, Guild S, Corda D, Axelrod J (1985) Hormone secretagogues increase cytosolic calcium by increasing cAMP in corticotropin-secreting cells. Proc Natl Acad Sci USA 82: 8034–8038PubMedGoogle Scholar
  66. Luini A, Lewis D, Guild S, Schofield G, Weight F (1986) Somatostatin, an inhibitor of ACTH secretion, decreases cytosolic free calcium and voltage-dependent calcium current in a pituitary cell line. J Neurosci 6: 3128–3137PubMedGoogle Scholar
  67. Lundblad JR, Roberts JL (1988) Regulation of proopiomelanocortin gene expression in pituitary. Endocr Rev 9: 135–158PubMedGoogle Scholar
  68. May V, Stoffers DA, Eipper BA (1989) Proadrenoocorticotropin/endorphin production and messenger ribonucleic acid levels in primary intermediate pituitary cultures: effects of serum, isoproternol, and dibutyrl adenosine 3’, 5’-monophosphate. Endocrinology 124: 157–166PubMedGoogle Scholar
  69. McEwen BS, De Kloet ER, Rostene W (1986) Adrenal steroid receptors and actions in the nervous system. Physiol Rev 66: 1121–1143PubMedGoogle Scholar
  70. McKnight SL, Kingsbury R (1982) Transcriptional control signals of a eukaryotic protein-coding gene. Science 217: 316–320PubMedGoogle Scholar
  71. Meador-Woodruff JH, Pellerito B, Bronstein D, Lin HL, Ling N, Akil H (1990) Differential effects of haloperiodol on the rat pituitary: decreased biosynthesis, processing and release of anterior lobe proopiomelanocortin. Neuroendocrinology 51: 294–303PubMedGoogle Scholar
  72. Mechanick JI, Levin N, Roberts JL, Autelitano DJ (in press) Proopiomelanocortin (POMC) gene expression in a distinct population of rat spleen and lung leukocytes. EndocrinologyGoogle Scholar
  73. Millington WR, Blum M, Knight R, Mueller GP, Roberts JL, O’Donohue TL (1986a) Diurnal rhythm in proopiomelanocortin messenger ribonucleic acid that varies concomitantly with the content and secretion of β-endorphin in the intermediate lobe of the rat pituitary. Endocrinology 118: 829–840PubMedGoogle Scholar
  74. Millington WR, O’Donohue TL, Chappel MC, Roberts JL, Mueller GP (1986b) Coordinate regulation of peptide acetyltransferase activity and proopiomelanocortin gene expression in the intermediate lobe of the rat pituitary. Endocrinology 118: 2024–33PubMedGoogle Scholar
  75. Mishina M, Kurosaki T, Yamamoto T, Notake M, Masu M, Numa S (1982) DNA sequences required for transcription in vivo of the human corticotropin-β-lipotropin precursor gene. EMBO J 1: 1533–1538PubMedGoogle Scholar
  76. Miyazki K, Reisine T, Kebabian JW (1984) Adenosine 3’, 5’-monophosphate (cAMP)-dependent protein kinase activity in rodent pituitary tissue: possible role in cAMP-dependent hormone secretion. Endocrinol 115: 1933–1942Google Scholar
  77. Murakami K, Hashimoto K, Ota Z (1985) The effect of nifedipine on CRF-41 and AVP-induced ACTH release in vitro. Acta Endocrinol 109: 32–39PubMedGoogle Scholar
  78. Nakamura N, Nakanishi S, Sueoka S, Imura H, Numa S (1978) Effects of steroid hormones on the level of corticotropin messenger RNA activity in cultured mouse-pituitary-tumor cells. Eur J Biochem 86: 61–68PubMedGoogle Scholar
  79. Nakanishi S, Kita T, Taii S, Imura H, Numa S (1977) Glucocorticoid effect on the level of corticotropin messenger RNA activity in rat pituitary. Proc Natl Acad Sci USA 74: 3283–3286PubMedGoogle Scholar
  80. Nakanishi S, Teranishi Y, Watanabe Notake M, Noda M, Kakidani H, Jingami H, Numa S (1981) Isolation and characterization of the bovine corticotropin/β-lipotropin precursor gene. Eur J Biochem 115: 429–438PubMedGoogle Scholar
  81. Notake M, Kurosaki T, Yamamoto T, Handa H, Mishina M (1983) Sequence requirement for transcription in vitro of the human corticotropin/β-lipotropin precursor gene. J Biochem 133: 599–608Google Scholar
  82. Oates E, Herbert E (1984) 5’ Sequence of porcine and rat pro-opiomelanocortin mRNA. J Biol Chem 259:7421–7425PubMedGoogle Scholar
  83. Oertel WH, Mugnaini E, Tappaz ML, Weise VK, Dahl AL, Schmechel DE, Kopin IJ (1982) Central GABAergic innervation of neurointermediate pituitary lobe: biochemical and immunocytochemical study in the rat. Neurobiology 79: 675–688Google Scholar
  84. Perrin MH, Haas Y, Rivier JE, Vale WW (1986) Corticotropin-releasing factor binding to the anterior pituitary receptor is modulated by divalent cations and guanyl nucleotides. Endocrinology 118: 1171–1180PubMedGoogle Scholar
  85. Pintar JE, Schacter BS, Herman AB, Durgerian S, Krieger DT (1984) Characterization and localization of proopiomelanocortin messenger RNA in the adult rat testes. Science 225: 632–634PubMedGoogle Scholar
  86. Pritchett DB, Roberts JL (1987) Dopamine regulates expression of glandular-type kallikrein gene at transcriptional level in pituitary. Proc Natl Acad Sci USA 84: 5545–5549PubMedGoogle Scholar
  87. Proulx-Ferland L, Labrie F, Dumont D, Cote J (1982) Corticotropin-releasing factor stimulates secretion of melanocyte-stimulating hormone from the rat pituitary. Science 217: 62–63PubMedGoogle Scholar
  88. Raymond V, Leung PCK, Veilleux R, Labrie F (1985) Vasopressin rapidly stimulates phosphatidic acid-phosphatidylinositol turnover in rat anterior pituitary cells. FEBS Lett 182: 196–200PubMedGoogle Scholar
  89. Rees H, Stumpf W, Sar M, Petrusz P (1977) Autoradiographic studies of 3H-dexamethasone uptake by immunocytochemically characterized cells of the rat pituitary. Cell Tiss Res 182: 347–359Google Scholar
  90. Reisine T, Rougon G, Barbet J, Affolter HU (1985) Corticotropin-releasing factor- induced adrenocorticotropin hormone release and synthesis is blocked by incorporation of the inhibitor of cyclic AMP-dependent protein kinase into anterior pituitary tumor cells by liposomes. Proc Natl Acad Sci USA 82: 8261–8265PubMedGoogle Scholar
  91. Reisine TD (1985) Somatostatin inhibition of cyclic AMP accumulation and adrenocorticotropin release from mouse anterior pituitary tumor cells: mode of action and self-regulation. Adv Cyclic Nucleotide Res 19: 169–184Google Scholar
  92. Reisine T, Guild S (1985) Pertussis toxin blocks somatostatin inhibition of calcium mobilization and reduces the affinity of somatostatin receptors for agonists. J Pharm Exp Ther 235: 551–558Google Scholar
  93. Reisine T, Zhang Y-L, Sekura R (1985) Pertussis toxin treatment blocks the inhibition of somatostatin and increases the stimulation by forskolin of cyclic AMP accumulation and adrenocorticotropin secretion from mouse anterior pituitary tumor cells. J Pharm Exp Ther 232: 275–280Google Scholar
  94. Riegel AT, Remenick J, Wolford RG, Berard DS, Hager GL (1990) A novel transcriptional activator ( PO-B) binds between the TATA box and cap site of the pro-opiomelanocortin gene. Nucleic Acids Res 18: 4513–4521Google Scholar
  95. Riegel AT, Yang L, Remenick J, Wolford RG, Berard DS, Hager GL (1991) Proopiomelanocortin gene promoter elements required for constitutive and glucocorticoid-repressed transcription. Mol Endocrinol 5: 1973–1982PubMedGoogle Scholar
  96. Ringold GM (1985) Steroid hormone regulation of gene expression. Ann Rev Pharmacol Toxicol 25: 529–559Google Scholar
  97. Roberts JL, Budarf MJ, Baxter JD, Herbert E (1979) Selective reduction of proadrenocorticotropin/endorphin protein and mRNA activity in mouse pituitary tumor cells by glucocorticoids. Biochemistry 18: 4907PubMedGoogle Scholar
  98. Roberts JL, Lundblad JR, Eberwine JH, Fremeau RT, Salton SRJ, Blum M (1987) Hormonal regulation of proopiomelanocortin gene expression in the pituitary. Ann NY Acad Sci 512: 275–285PubMedGoogle Scholar
  99. Roberts JL, Lorang D, Boutillier L, Lundblad JL, Dermer S, Salton SRJ, Loeffler JP (to be published) Characterization of the rat POMC promoter elements responsible for CRH stimulated transcription. J Biol ChemGoogle Scholar
  100. Rotsztejn WH, Dussaillant M, Nobou F, Rosselin G (1981) Rapid glucocorticoid inhibition of vasoactive intestinal peptide-induced cyclic AMP accumulation and prolactin release in rat pituitary cells in culture. Proc Natl Acad Sci USA 78: 7584–7588PubMedGoogle Scholar
  101. Sabol SL (1980) Storage and secretion of β-endorphin and related peptides by mouse pituitary tumor cells: regulation by glucocorticoids. Arch Biochem Biophys 203: 37PubMedGoogle Scholar
  102. Schachter BS, Johnson LK, Baxter JD, Roberts JL (1982) Differential regulation by glucocorticoids of proopiomelanocortin mRNA levels in the anterior and intermediate lobes of the rat pituitary. Endocrinology 110: 1442–1444PubMedGoogle Scholar
  103. Schoenenberg P, Kehrer P, Muller AF, Gaillard RC (1987) Angiotensin II potentiates corticotropin-releasing activity of CRF41 in rat anterior pituitary cells: mechanism of action. Neuroendocrinology 45: 86–96PubMedGoogle Scholar
  104. Simard J, Labrie F, Gossard F (1986) Regulation of growth hormone mRNA and proopiomelanocortin mRNA levels by cyclic AMP in rat anterior pituitary cells in culture. DNA 5: 263–270PubMedGoogle Scholar
  105. Takakashi H, Hakamata Y, Watanabe Y, Kikuno R, Miyata T, Numa S (1983) Complete nucleotide sequence of the human corticotropin-β-lipotropin precursor gene. Nucleic Acids Res 11: 6847–6856Google Scholar
  106. Taleb O, Loeffler JP, Trouslard J, Demeneix BA, Kley N, Höllt V, Feltz P (1986) Ionic conductances related to GABA action on secretory and biosynthetic activity of pars intermedia cells. Brain Res Bull 17: 725–731PubMedGoogle Scholar
  107. Therrien M, Drouin J (1991) Pituitary pro-opiomelanocortin gene expression requires synergistic interactions of several regulatory elements. Mol Cell Biol 11: 3492–3503PubMedGoogle Scholar
  108. Tremblay Y, Tretjakoff I, Peterson A, Atakly T, Zhang CX, Drouin J (1988) Pituitary-specific expression and glucocorticoid regulation of pro-opiomelanocortin ( POMC) fusion gene in transgenic mice. Proc Natl Acad Sci USA 85: 8890–8894PubMedGoogle Scholar
  109. Uhler M, Herbert E, Deustachio P, Ruddle FD (1983) The mouse genome contains two nonallelic pro-opiomelanocortin genes. J Biol Chem 258: 9444–9457PubMedGoogle Scholar
  110. Vale W, Vaughn J, Smith M, Yamamoto G, Rivier J, Rivier C (1983) Effects of synthetic oCRF, glucocorticoids, catecholamines, neurohypophysial peptides and other substances on cultured corticotrophic cells. Endocrinology 113: 121–131Google Scholar
  111. Warembourg M (1975) Radioautographic study of the rat brain and pituitary after injection of 3H dexamethasone. Cell Tiss Res 161: 183–197Google Scholar
  112. Widmaier EP, Dallman MF (1984) The effects of corticotropin-releasing factor on adrenocorticotropin secretion from perifused pituitaries in vitro: rapid inhibition by glucocorticoids. Endocrinology 115: 2368–2379PubMedGoogle Scholar
  113. Yang-Yen HF, Chambard JC, Sun YL, Smeal T, Schmidt T, Drouin J, Karin J (1990) Transcriptional interference between c-jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62: 1189–1204Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • J. L. Roberts
  • N. Levin
  • D. Lorang
  • J. R. Lundblad
  • S. Dermer
  • M. Blum

There are no affiliations available

Personalised recommendations